Meiling Zhang

462 citations
21 papers · 293 indexed · h-index 9
Topics
Lung Cancer Treatments and Mutations (4 papers)Gastric Cancer Management and Outcomes (3 papers)Liver Disease Diagnosis and Treatment (2 papers)
Partner nations
ChinaSwedenUnited States

In The Last Decade

Meiling Zhang

20 papers receiving 289 citations

Peers

Meiling Zhang
Comparison fields: 5 of 82
  • Molecular Biology 92
  • Surgery 64
  • Epidemiology 53
  • Infectious Diseases 52
  • Pulmonary and Respiratory Medicine 36
Replace Sibel Hacıoğlu with:
Sibel Hacıoğlu Türkiye
Enqiang Mao China
Jieyao Li China
Shou-Chuan Shih Taiwan
Morteza Samadi Iran
Xueli Ding China
C. Brown United Kingdom
Junli Zhang China
Kun Guo China
Weihua Dong China
Meiling Zhang relative to Sibel Hacıoğlu Türkiye Sibel Hacıoğlu's profile →
Citations per field
00.5×2.6×
Sibel Hacıoğlu · 1×
Citations per year

Countries citing papers authored by Meiling Zhang

Since Specialization
Citations

This map shows the geographic impact of Meiling Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meiling Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meiling Zhang more than expected).

Fields of papers citing papers by Meiling Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meiling Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meiling Zhang. The network helps show where Meiling Zhang may publish in the future.

Co-authorship network of co-authors of Meiling Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Meiling Zhang. A scholar is included among the top collaborators of Meiling Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meiling Zhang. Meiling Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 5
2 0
3 2
4 2
5 9
6 11
7 1
8 2
9 5
10 6
11 72
12 10
13 4
14 52
15 66
16 16
17 4
18 12
19 5
20
Clinical Observation of Icotinib Hydrochloride in the Treatment for Advanced Non-small Cell Lung Cancer
1

About Meiling Zhang

Meiling Zhang is a scholar working on Hepatology, Transplantation and Clinical Biochemistry, having authored 21 papers that have together received 293 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (4 papers), Gastric Cancer Management and Outcomes (3 papers) and Liver Disease Diagnosis and Treatment (2 papers). The work is most often cited by research in Drug Discovery (1 citation), Hepatology (36 citations) and Geriatrics and Gerontology (17 citations). Meiling Zhang has collaborated with scholars based in China, Sweden and United States. Frequent co-authors include Cheng Jiang, Xiaodong Wang, Ying Yin, Xueshan Sun, Shuyan Gu, Yuanyuan Li, Xuemei Zhen, Yuxuan Gu, Xiaoqian Hu and Hengjin Dong. Their work appears in journals such as PLoS ONE, Scientific Reports and Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026